Repurposed Drugs Pose an Ethical Challenge for Physicians

Repurposed Drugs Pose an Ethical Challenge for Physicians

A recent article (with 504 references!) published in Signal Transduction and Target Therapy explored many of these interventions, their potential mechanism of action, and the current understanding of their benefits.1 I also came across a YouTube video by The Economist about a woman with metastatic b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Targeted therapies in oncology 2025-01, Vol.13 (16)
1. Verfasser: Busby, Leslie
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Cancer therapies
Drugs
Oncology, Experimental
Patients
Signal transduction
Vascular endothelial growth factor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 16
container_start_page
container_title Targeted therapies in oncology
container_volume 13
creator Busby, Leslie
description A recent article (with 504 references!) published in Signal Transduction and Target Therapy explored many of these interventions, their potential mechanism of action, and the current understanding of their benefits.1 I also came across a YouTube video by The Economist about a woman with metastatic breast cancer who was told she only had "5 years to live. Unfortunately, this fallacy is common in health care.3 Currently, using repurposed drugs puts physicians in an ethical conflict. On the one hand, these are inexpensive drugs with usually tolerable and manageable toxicities, so the overall financial and health care cost is low.
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3151542578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A822373655</galeid><sourcerecordid>A822373655</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1008-eded47de2621b6d552a769832d4ce543a37529b15370fe0267790363bc5e2de63</originalsourceid><addsrcrecordid>eNptj0FLxDAQhYMouKz7HwJevFTSSZM0x2VddWHBRfRc0mTaRrLt2rQH_72R9eBB5jCPxzePNxdkAUqqTALIS7LIBddZmfQ1WcX4wRgDDaAZWxD9iqd5PA0RHX0Y5zbSQ9LU9HQ7dd6aQDedCQH7FmkzjPTQfUVvvenjDblqTIi4-t1L8v64fds8Z_uXp91mvc_anLEyQ4euUA5BQl5LJwQYJXXJwRUWRcENVwJ0nSoq1iADqZRmXPLaCgSHki_J3Tn3NA6fM8apOvpoMQTT4zDHiuciFwUIVSb09oy2JmDl-2aYRmN_8Gqd3ueKSyESdf8Plcbh0duhx8Yn_8_BNzl_YEw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151542578</pqid></control><display><type>article</type><title>Repurposed Drugs Pose an Ethical Challenge for Physicians</title><source>ProQuest Central</source><creator>Busby, Leslie</creator><creatorcontrib>Busby, Leslie</creatorcontrib><description>A recent article (with 504 references!) published in Signal Transduction and Target Therapy explored many of these interventions, their potential mechanism of action, and the current understanding of their benefits.1 I also came across a YouTube video by The Economist about a woman with metastatic breast cancer who was told she only had "5 years to live. Unfortunately, this fallacy is common in health care.3 Currently, using repurposed drugs puts physicians in an ethical conflict. On the one hand, these are inexpensive drugs with usually tolerable and manageable toxicities, so the overall financial and health care cost is low.</description><identifier>ISSN: 1539-8226</identifier><identifier>EISSN: 2767-6226</identifier><language>eng</language><publisher>Cranbury: Intellisphere, LLC</publisher><subject>Cancer ; Cancer therapies ; Drugs ; Oncology, Experimental ; Patients ; Signal transduction ; Vascular endothelial growth factor</subject><ispartof>Targeted therapies in oncology, 2025-01, Vol.13 (16)</ispartof><rights>COPYRIGHT 2025 Intellisphere, LLC</rights><rights>Copyright MultiMedia Healthcare Inc. 2025</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3151542578?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21407,33722,43781</link.rule.ids></links><search><creatorcontrib>Busby, Leslie</creatorcontrib><title>Repurposed Drugs Pose an Ethical Challenge for Physicians</title><title>Targeted therapies in oncology</title><description>A recent article (with 504 references!) published in Signal Transduction and Target Therapy explored many of these interventions, their potential mechanism of action, and the current understanding of their benefits.1 I also came across a YouTube video by The Economist about a woman with metastatic breast cancer who was told she only had "5 years to live. Unfortunately, this fallacy is common in health care.3 Currently, using repurposed drugs puts physicians in an ethical conflict. On the one hand, these are inexpensive drugs with usually tolerable and manageable toxicities, so the overall financial and health care cost is low.</description><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Drugs</subject><subject>Oncology, Experimental</subject><subject>Patients</subject><subject>Signal transduction</subject><subject>Vascular endothelial growth factor</subject><issn>1539-8226</issn><issn>2767-6226</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptj0FLxDAQhYMouKz7HwJevFTSSZM0x2VddWHBRfRc0mTaRrLt2rQH_72R9eBB5jCPxzePNxdkAUqqTALIS7LIBddZmfQ1WcX4wRgDDaAZWxD9iqd5PA0RHX0Y5zbSQ9LU9HQ7dd6aQDedCQH7FmkzjPTQfUVvvenjDblqTIi4-t1L8v64fds8Z_uXp91mvc_anLEyQ4euUA5BQl5LJwQYJXXJwRUWRcENVwJ0nSoq1iADqZRmXPLaCgSHki_J3Tn3NA6fM8apOvpoMQTT4zDHiuciFwUIVSb09oy2JmDl-2aYRmN_8Gqd3ueKSyESdf8Plcbh0duhx8Yn_8_BNzl_YEw</recordid><startdate>20250104</startdate><enddate>20250104</enddate><creator>Busby, Leslie</creator><general>Intellisphere, LLC</general><general>MultiMedia Healthcare Inc</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20250104</creationdate><title>Repurposed Drugs Pose an Ethical Challenge for Physicians</title><author>Busby, Leslie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1008-eded47de2621b6d552a769832d4ce543a37529b15370fe0267790363bc5e2de63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Drugs</topic><topic>Oncology, Experimental</topic><topic>Patients</topic><topic>Signal transduction</topic><topic>Vascular endothelial growth factor</topic><toplevel>online_resources</toplevel><creatorcontrib>Busby, Leslie</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Targeted therapies in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busby, Leslie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Repurposed Drugs Pose an Ethical Challenge for Physicians</atitle><jtitle>Targeted therapies in oncology</jtitle><date>2025-01-04</date><risdate>2025</risdate><volume>13</volume><issue>16</issue><issn>1539-8226</issn><eissn>2767-6226</eissn><abstract>A recent article (with 504 references!) published in Signal Transduction and Target Therapy explored many of these interventions, their potential mechanism of action, and the current understanding of their benefits.1 I also came across a YouTube video by The Economist about a woman with metastatic breast cancer who was told she only had "5 years to live. Unfortunately, this fallacy is common in health care.3 Currently, using repurposed drugs puts physicians in an ethical conflict. On the one hand, these are inexpensive drugs with usually tolerable and manageable toxicities, so the overall financial and health care cost is low.</abstract><cop>Cranbury</cop><pub>Intellisphere, LLC</pub></addata></record>
fulltext fulltext
identifier ISSN: 1539-8226
ispartof Targeted therapies in oncology, 2025-01, Vol.13 (16)
issn 1539-8226
2767-6226
language eng
recordid cdi_proquest_miscellaneous_3151542578
source ProQuest Central
subjects Cancer
Cancer therapies
Drugs
Oncology, Experimental
Patients
Signal transduction
Vascular endothelial growth factor
title Repurposed Drugs Pose an Ethical Challenge for Physicians
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T15%3A16%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Repurposed%20Drugs%20Pose%20an%20Ethical%20Challenge%20for%20Physicians&rft.jtitle=Targeted%20therapies%20in%20oncology&rft.au=Busby,%20Leslie&rft.date=2025-01-04&rft.volume=13&rft.issue=16&rft.issn=1539-8226&rft.eissn=2767-6226&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA822373655%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151542578&rft_id=info:pmid/&rft_galeid=A822373655&rfr_iscdi=true